Robert Webb Biography and Net Worth



Robert T. Webb serves as Independent Director of the Company. Mr. Webb has served as a director of the Company since its inception in 1991. Mr. Webb is the owner of commercial buildings in the Middle Tennessee area and is a subdivision developer. Additionally, Mr. Webb is the Vice President and Treasurer of Webb’s Refreshments, Inc., which has been in operation serving the Middle Tennessee area since 1976. Mr. Webb served as President of Webb’s Refreshments until that position was assumed by his son in 2010. He attended David Lipscomb College and received a Bachelor of Arts in business marketing from Middle Tennessee State University in 1969.

What is Robert T. Webb's net worth?

The estimated net worth of Robert T. Webb is at least $3.98 million as of June 17th, 2021. Mr. Webb owns 63,339 shares of National Health Investors stock worth more than $3,980,856 as of April 24th. This net worth evaluation does not reflect any other assets that Mr. Webb may own. Learn More about Robert T. Webb's net worth.

How do I contact Robert T. Webb?

The corporate mailing address for Mr. Webb and other National Health Investors executives is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. National Health Investors can also be reached via phone at (615) 890-9100 and via email at [email protected]. Learn More on Robert T. Webb's contact information.

Has Robert T. Webb been buying or selling shares of National Health Investors?

Robert T. Webb has not been actively trading shares of National Health Investors in the last ninety days. Most recently, on Wednesday, December 1st, Robert T. Webb bought 2,000 shares of National Health Investors stock. The stock was acquired at an average cost of $51.60 per share, with a total value of $103,200.00. Learn More on Robert T. Webb's trading history.

Are insiders buying or selling shares of National Health Investors?

In the last year, National Health Investors insiders bought shares 2 times. They purchased a total of 11,000 shares worth more than $638,300.00. The most recent insider tranaction occured on February, 27th when Director Charlotte A Swafford bought 10,000 shares worth more than $586,900.00. Insiders at National Health Investors own 8.2% of the company. Learn More about insider trades at National Health Investors.

Information on this page was last updated on 2/27/2024.

Robert T. Webb Insider Trading History at National Health Investors

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2021Buy2,000$51.60$103,200.00View SEC Filing Icon  
11/29/2021Buy1,000$52.86$52,860.00View SEC Filing Icon  
9/30/2021Buy2,000$53.86$107,720.00View SEC Filing Icon  
9/16/2021Buy1,500$57.50$86,250.00View SEC Filing Icon  
9/14/2021Buy1,500$58.00$87,000.00View SEC Filing Icon  
6/17/2021Buy1,184$65.00$76,960.0063,339View SEC Filing Icon  
3/16/2020Buy2,151$46.28$99,548.2863,339View SEC Filing Icon  
8/25/2015Buy5,000$56.75$283,750.0054,473View SEC Filing Icon  
See Full Table

Robert T. Webb Buying and Selling Activity at National Health Investors

This chart shows Robert T Webb's buying and selling at National Health Investors by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

National Health Investors Company Overview

National Health Investors logo
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More

Today's Range

Now: $62.85
Low: $61.65
High: $62.94

50 Day Range

MA: $59.38
Low: $53.21
High: $62.85

2 Week Range

Now: $62.85
Low: $47.54
High: $63.19

Volume

128,753 shs

Average Volume

172,629 shs

Market Capitalization

$2.73 billion

P/E Ratio

20.08

Dividend Yield

5.78%

Beta

0.95